Table of Contents Author Guidelines Submit a Manuscript
Minimally Invasive Surgery
Volume 2012 (2012), Article ID 696348, 7 pages
Review Article

Laparoscopic Gastric Plication for the Treatment of Morbid Obesity: A Review

1Department of Surgery, Manchester Royal Infirmary, Manchester M13 9LL, UK
2Department of Transplantation, Royal London Hospital, London E1 1BB, UK
3Department of Surgery, Veroia General Hospital, Veroia 591 00, Greece
4Department of Surgery, Evangelismos General Hospital, Athens 10675, Greece
5Department of Minimally Invasive and Robotic Surgery, Athens University Medical School, Athens 11527, Greece

Received 13 December 2011; Revised 27 April 2012; Accepted 31 May 2012

Academic Editor: Casey M. Calkins

Copyright © 2012 Michael Kourkoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. Laparoscopic greater curvature plication is an operation that is gaining ground in the treatment of morbid obesity, as it appears to replicate the results of laparoscopic sleeve gastrectomy with fewer complications. Aim. Review of current literature, especially results on weight loss and complications. Method. 11 (eleven) published articles on laparoscopic gastric plication, of which 1 preclinical study, 8 prospective studies for a total of 521 patients and 2 case reports of unusual complications. Results. Reported Paracentage of EWL in all studies is comparable to Laparoscopic Sleeve Gastrectomy (around 50% in 6 months, 60–65% in 12 months, 60–65% in 24 months) and total complication rate is at 15,1% with minor complications in 10,7%, major complications in 4,4%. Reoperation rate was 3%, conversion rate was 0,2%, and mortality was zero. Conclusion. Current literature on gastric plication and its modifications is limited and sketchy at times. Low cost, short hospital stay, absence of prosthetic material, and reversibility make it an attractive option. Initial data show that LGCP is effective for short- and medium-term weight loss, complication and reoperation rates are low, and GERD symptoms are unaffected. More data is required, and randomized control trials must be completed in order to reach safe conclusions.